LIVN

LIVN

LivaNova PLC Ordinary Shares

$46.630+-0.000 (-0.000%)

Real-time Price

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$46.630

High

$46.630

Low

$46.630

Volume

0.67M

Company Fundamentals

Trading Stats

Related News

BusinessWire

CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced

View more
CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
BusinessWire

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

Final critical papers on RECOVER clinical study data accepted, supporting the Company's submission for coverage reconsideration Strong 24-month top-line data for RECOVER clinical study demonstrates durability of VNS

View more
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
Analyst Upgrades

Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target

Wolfe Research analyst Mike Polark upgrades LivaNova from Peer Perform to Outperform and announces $60 price target.

View more
Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target